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The anomalies of X chromosome are classified as numerical or structural. Concomitant structural anomalies in this chromosome
that associate partial loss of its long arm with duplications in its short arm are uncommon. Only a few cases have been published
and in most of them the reported patients present ovarian dysfunction, tall stature, and overdosage of the SHOX gene with locus
Xp22.33. Considering these reports, we evaluated the case of a woman with a deletion in the long arm of the X chromosome,
premature ovarian failure, tall stature, and multiple arterial vascular disease.With the aim to find a relationship between karyotype
and phenotype, we explored associated anomalies in Xp and certified the overdosage of the SHOX gene in this case byMLPA. Also,
taking into account the fact that the gene locus of the angiotensin-converting enzyme type 2 (ACE2) is located in Xp, our goal was
to investigate the influence of this gene in the development of cardiovascular disease.The detection of the gene product of ACE2 by
ELISA was undetectable.We have proposed that cytogenetic anomalies in X chromosome could contribute to decrease this protein
synthesis in this gender.
1. Introduction
The anomalies of X chromosome are classified as numerical
or structural and can affect short arm (Xp) or long arm
(Xq). The most studied are cluster under the name of
Turner syndrome (TS).This group includesmonosomy as the
majority but also losses (deletions), duplications, inversions,
and chromosomal rings that affect the X chromosome. The
increase in morbidity and mortality is a cardinal feature in
patients with TS, describing in them a risk of premature death
three times greater than that of the general population and life
expectancy decreased by at least a decade [1]. Patients with
TS have multisystemic complications [2] but cardiovascular
disease is the main cause of the decline in life expectancy [1].
The correlation between karyotype and phenotype
expression in this group of patients has been probed [3].
Concomitant structural abnormalities in X chromosome
that include partial Xq deletion with Xp duplication
are uncommon. In the few cases reported, ovarian
dysfunction associated with very tall stature has been
frequent clinical features [4–6]. In the majority of these
patients, an overdosage of SHOX gene associated with the
condition was certified. In the evaluation of these cases,
some authors have reported that an extra copy of SHOX gene
could be necessary but not enough for the development of
tall stature in similar patient with gonadal dysgenesis [7].
The SHOX gene (short stature homeobox-containing gene)
is most strongly expressed in marrow fibroblast but is widely
expressed in limbs, pharyngeal arches, and osteogenic cells
too and is implied in the final height determination [8, 9].
SHOX is located on pseudoautosomal region (PAR1) in
sexual chromosomes (Xp22.3 and Yp11.3). Genes located in
PAR1 are represented by two active copies producing a dosage
effect of the SHOXgene in patients with sexual chromosomes
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aberrations. This is due to the fact that several loci in Xp22.3
suffer an incomplete inactivation [10]. Depending on the
altered SHOX dosage, haploinsufficiency causes short stature
while overdosage contributes to tall stature [11].
The precise mechanisms of increased cardiovascular risk
in TS remain unclear [12]. Different authors have proposed
several candidates genes as TGF𝛽, VEGF, etc. but their
participation in the pathophysiology of disease is unknown
[13, 14].
Considering that the locus of the angiotensin I converting
enzyme type 2 (ACE2) is located in the short arm of the
X chromosome, we proposed to investigate the influence
of this gene in the development of endothelial dysfunction
and cardiovascular disease in a patient who consulted by
premature ovarian failure, tall stature, and multiple and
severe arterial vascular disease for her age. The influence
of ACE2 gene has not been studied in patients with X
chromosomes aberrations. Also, considering that, in similar
cases reported, deletions in Xq could be associated with
duplications of the SHOX gene in Xp; we certified that tall
stature in our patient is associated with duplication of this
gene through MLPA (multiplex ligation- dependent probe
amplification) methodology.
2. Case Report
The proband is 28 years old and is the only daugh-
ter of nonconsanguineous parents. A maternal height of
152 cm and a paternal height of 161 cm were recorded.
Among her antecedents she presents secondary amen-
orrhea, primary hypothyroidism, hyperinsulinism, insulin
resistance, and premature ovarian failure. The complemen-
tary tests showed uterine hypoplasia and small ovaries and
hypergonadotrophic hypogonadism, with normal andro-
genic profile and normal growth hormone (GH). Her serum
luteinizing hormone (LH) and follicle-stimulating hormone
(FSH) were 23.20 mIU/ml and 23.90 mIU/ml, respectively.
Her serum estradiol was <10mg/ml. Her serum testosterone
and dehydroepiandrosterone were normal values (0.28 ng/ml
and 107 ug/dl, respectively). Her serum insulin-like growth
factor-1 (IGF-1) was normal (327 ng/ml).
The karyotype in peripheral blood lymphocytes showed
46, X,del(X),(q22-q27). In the physical examination she pre-
sented macrocephaly, upslanting palpebral fissures, and fron-
tomalar prominence. Acanthosis nigricans were observed in
the neck. In the upper limbs there was cutaneous syndactyly
of the lower third and bilateral fifth finger clinodactyly. In
lower limbs there was separation of the first toe; brachy-
dactyly of the 4th and 5th toes in the left foot and in the
right foot 5th finger was overlapping over the 4th (Figure 1).
Her height was 186 cm and her weight was 97 kg (weight and
height were above the 97th centile).
3. Methods
3.1. Vascular Ultrasound. A carotid ultrasound scan was
performed with a Siemens Acuson X700 ultrasound machine
equipped with vascular health software (syngo arterial health
Figure 1: Physical examination: note frontomalar prominence in the
face. In the upper limbs there was cutaneous syndactyly of the lower
third and bilateral fifth finger clinodactyly. In lower limbs there was
separation of the first toe; brachydactyly of the 4th and 5th toes in
the left foot and in the right foot 5th finger was overlapping over the
4th.
package) and linear transducer from 7.5 to 12MHz.The artery
is scanned and the diameter is measured, in the longitudinal
section, in three regions (CCA: common carotid artery,
CB: carotid bulb, and ICA: internal carotid artery). B-mode
ultrasound images of the CCA, CB, and ICA segments were
obtained and the image files were recorded. To determine
the parameters of dynamic endothelial dysfunction in the
brachial artery (FMD: flow-mediated dilatation) the non-
dominant arm was placed in the patient in a permanent and
immobilized position to allow access to the brachial artery
with the transducer. The artery image was obtained 3 to 7
cm above the antecubital fold with a linear transducer with
a frequency of 7.5 MHz. The measurements are coordinated
at the end of diastole. After the determination of the arterial
diameter at basal, a pressure cuff was placed distal to the
transducer and applied at a pressure of 200 mmHg for 5 min
and then quickly released the occlusion. At the first minute of
release of the occlusion, the arterial diameter was measured
to evaluate the response to hyperemia.
3.2. SHOX Gene Analysis by MLPA: PARs Analysis. The
Multiplex Ligation-dependent Probe Amplification (MLPA)
probemix P018-G1 SHOX was employed to search for
PAR1/PAR2 deletions and duplications, using conditions
specified by the manufacturer (MRC-Holland, Amsterdam,
The Netherlands; http://www.mrc-holland.com). This kit
contains probes for each exon of SHOX, as well as probes
upstream and downstream of SHOX, where SHOX regulatory
elements are located (CNE). Furthermore, several probes in
the X-specific region of the X chromosome were included to
characterize large deletions. Finally, nine autosomal reference
probes were included for normalization. The MLPA data
analysis was performed using Coffalyser. Net software is
freely downloadable at www.mlpa.com. A value below 0.7 or
above 1.3 is regarded as indicative of a heterozygous deletion
(copy number change from two to one allele) or duplication
(copy number change from two to three or more alleles),
respectively.
3.3. Measure of ACE2 by ELISA. We used an enzyme-
linked immunosorbent assay (ELISA) for quantitative deter-
mination of ACE2 in human urine samples provided for
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(a) (b)
Figure 2: The vascular ultrasound study in our patient showed atherogenic plates: (a) 1.6 mm in RCCA (right common carotid artery) and
(b) 2 mm in LCCA (left common carotid artery).
(a) (b)
Figure 3: In FMD (flow-mediated dilation) in brachial artery patient did not present vascular reactivity in the first minute and this was
interpreted as endothelial dysfunction.
BioSource. Polyclonal antibody specific for human ACE2
has been precoated onto 96-well microplate. Standards and
sample are pipeted into the wells and any ACE2 present is
bound by immobilized antibody. Bound ACE2 is captured
by biotinylated anti-human ACE2 polyclonal antibody. HRP
conjugated streptavidin is added. After washing, a substrate
solution is added. The colors develop in proportion to the
bounded ACE quantity. The color development is stopped
and the intensity of color is measured.
4. Results
The vascular ultrasound study in our patient showed an
atherogenic plate of 1.6 mm in RCCA (right common carotid
artery) and 2 mm in LCCA (left common carotid artery)
(Figure 2). In FMD in brachial artery our patient did not
present vascular reactivity in the first minute and this was
interpreted as endothelial dysfunction (Figure 3).
MLPA analysis confirmed the duplication that involve
the entire PAR1 region and spread to the FANCB gene
located in Xp22.2 (Figures 4 and 5). Note the extension of
the duplicated region; FANCB gene locus is really close to
ACE2 gene, but the latter has a more centromeric position
(Figure 6). It is necessary to emphasize that the MLPA Kit
does not have control sequences for the ACE2 gene; for this
reason the ELISA technique was used, in order to indirectly
determine alterations in gene function. For another hand a
haploinsufficiency of VAMP7 gene was detected in long arm
























































































































































































































































































Figure 4: PARs alterations detected by MLPA. (Up) PARs are depicted with blue lines over sexual chromosome diagram; (middle) name and
position (Kb from p-telomere) of each MLPA SALSA P018-G1 probe are indicated with a grey square (diagram not drawn to scale); (down)
MLPA analysis result where black triangle (󳵳) reduced copy number (<2) and inverted black triangle (󳶃) increased copy number (>2) of the
MLPA specific probe. CNE: conserved noncoding elements.
Figure 5: Multiple ligation-dependent probe amplification (MLPA) analysis was performed using a SALSA MLPA P018-G1. Reference Kit
(MRC-Holland, Amsterdam, The Netherlands) according to the manufacturer’s instruction. The MLPA data analysis was performed using
Coffalyser. To right Coffalyser sheet showing the ratios calculated for each probe. A value below 0.7 or above 1.3 is regarded as indicative of a
heterozygous deletion (copy number change from two to one allele) or duplication (copy number change from two to three or more alleles),
respectively.This kit contains probes for each exon of SHOX, as well as probes upstream and downstream of SHOX, where SHOX regulatory
elements are located (CNE). Furthermore, several probes in the X-specific region of the X chromosome were included to characterize large
deletions. Finally, nine autosomal reference probes were included for normalization.
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q28q25q23q21.1p22.2
(a) Normal X chromosome structure
q28q25q23q21.1p22.2
(b) Estimated size of deletion according to karyotype (G- banding chromosome)
q28q25q23q21.1p22.2
FANCB gene. Cytogenetic location: Xp22.2 Genomic coordinates (GRCh38): X:14,690,862-14,873,254 (from NCBI)
ACE2 Gene. Cytogenetic location: Xp22.2 Genomic coordinates (GRCh38): X:15,494,519-15,602,068 (from NCBI)
(c) Location of ACE2 gene in short arm
Figure 6: (a) X chromosome diagram. (b) In orange brackets, size of deletion in long arm of X chromosome is delimited. No aberrations
in short arm were informed. (c) The location of different genes (FANCB and ACE2) is marked in diagram of X chromosome (short arm).
Duplication informed by MLPA involves the entire PAR1 and spread until FANCB gene (red dashed arrow). ACE2 gene (blue dashed arrow)
is located next to FANCB.The activity of ACE2 was measured by ELISA methodology.
of X chromosome (Figures 4 and 5).This allowed us to specify
that the size of deletion in the long arm of the X chromosome
spread to a more terminal position than that defined by G
banded karyotype.
The value of ACE2 in urine by ELISA was undetectable.
The measurement of ACE2 was compared with the standard
value published by the manufacturer for normal controls
(ACE2 levels range in urine in healthy donors from 1
to 10 ng/ml). Female and male controls evaluated in our
group demonstrated values contained in the normal range,
including the parents of the patient (median of 4 pg/ml). In
addition, the value of the sample was compared with women
with secondary amenorrheawhohad normal karyotype (who
showed lower values but in normal range of ACE2) and
menwith Klinefelter syndromewith karyotype 47, XXY (who
presented values higher than the normal range of ACE2).
5. Discussion
SHOX gene is known to play an important role in grown
determination in human beings. The clinical signs as short
stature, gonadal dysgenesis, and somatic malformations in
patients with Turner syndrome are caused by partial or
total haploinsufficiency of one of the X chromosomes. Ogata
et al. [5] concluded that the combination between SHOX
overdosage and estrogen deficiency was necessary to explain
tall stature in many patients. According to del Rey G et
al. [9], the combination of SHOX gene triplication and
estrogen deficiency is not always produce tall stature. The
heterogeneity in phenotype of different patients could be due
to certain variants in their karyotype and we should consider
the role of X-inactivation center where genes located near
the breakpoints are also affected. In our patient, considering
the cytogenetic formula and adding her clinical features, the
SHOX gene overdosage probably explains her tall stature in a
context of estrogen deficiency.
Among the candidate genes, those involved in the renin
angiotensin system (RAS) have been some of the most
studied in different attempts to establish their participation
in pathophysiology of cardiovascular disease. However, its
influence on the vascular disease of patients with X chro-
mosome aberrations is not yet clear. We present the case of
a patient with Turner syndrome where the aim was to ana-
lyze the relationship between karyotype and cardiovascular
phenotype. We evaluate cardiovascular risk using vascular
ultrasound Doppler and dosage of ACE2 by ELISA technique
considering that the locus of ACE2 gene is located in short
arm of X chromosome. The measurement of his protein
by ELISA was undetectable in this patient. Cardiovascular
studies have shown that a rapid and nonnuclear signaling
pathway is involved in the estrogen-mediated protection
against diseases. This signaling has been studied in vascular
and endothelial smooth muscle cells where the coupling
between estrogen and its receptor causes the rapid activation
of endothelial nitric oxide synthase (eNOS) and production
of nitric oxide (NO) [15, 16]. For another hand, experimental
animal and clinical researches suggest that the components
of RAS are markedly affected by gender [17, 18]. Evidence
demonstrated that premenopausal women, as compared to
aged-matched men, are protected from cardiovascular dis-
ease [19]. With growing age, this cardiovascular protection
is lost [20]. This has been demonstrated in the work of
Bukowska et al. [20], where the administration of 17𝛽-
estradiol in human atrial myocardiocytes culture substan-
tially modulates the local RAS via, increases the amount of
mRNAACE2, and simultaneously causes upregulation in the
expression of AT2R (angiotensin receptor type 2) and MAS
receptor. Particularly in our case, hypoestrogenism could
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contribute to the decrease ACE2 values in urine, considering
that, according to the literature, the concentration of ACE2
protein is proportional to the amount of estrogen in women.
However, the undetectable values of ACE2 in our patient
allow us to suppose that the type of cytogenetic anomaly
probably contributes to decreasing the protein synthesis,
especially when compared with women with amenorrhea
and normal karyotype who present normal values of ACE2
protein. The hypoestrogenism could explain also vascular
disease and endothelial dysfunction. Our results obtained in
the vascular ultrasound in the brachial artery are coincident
with those published in the literature considering that the
absence of flow-mediated dilation (vascular reactivity) is a
mechanism dependent of NO.
The literature cites that deletions in long arm of X
chromosome (Xq) can manifest varied alterations in the
cycles (menstrual irregularities, amenorrhea, or premature
ovarian failure). It has also been described that the loss of
segment Xq26 can destabilize the short arm and there are few
cases of descriptions with deletion in this region associated
with duplication in the short arm (Xp). The duplication
of genes in short arm for our patient is nearby to ACE2
gene locus. The G banded karyotype’s resolution did not
allow identifying this kind of alterations that were clinically
suspected in our case. The duplication of the SOHX gene, as
well as other genes located in Xp, was certified trough MLPA
methodology. This same technique also allowed specifying
the size of the deletion in Xq through control sequences
located in the long arm of the chromosome.
In conclusion, we emphasize the importance to assess the
clinical characteristics and phenotype of the patient when
conducting different genetic studies. Finally, we support that,
in patients with similar clinical features and deletions in Xq,
the need to rule out associated alterations in Xp using more
precise techniques such as MLPA or array-CGH (array based
comparative genomic hybridization) should be considered.
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